TRIM33 and cancer: Collectively, the cutaneous phenotype offers valuable clues: severe skin disease can be associated with anti-TIF1γ antibodies and a higher risk of cancer [17,18], while a florid and acute cutaneous onset may suggest the presence of anti-SAE antibodies [24].